![]() We conclude that DDST II at 6 months of age could be used in predicting severe neurological outcome in infants with HIE. denver developmental screening test ii denver ii Wed, 05:40:00 GMT denver developmental screening test ii pdf Child must perform standing denver ii test items 2001 denver ii bell 2001 11.00 denver articulation screening exam 3000 dase picture cards 3000 20.00 3110 dase test forms 20. ![]() However, DDST II at 6 months of age, yielded a very high predictive accuracy (sensitivity=100%, specificity=95%). Cranial US had 100% sensitivity, however with a rather low specificity (55%). Among the predictors of severe adverse outcome, occurrence of seizures was found to have a poor predictive accuracy. Twenty of the remaining 47 infants had a severe adverse outcome. Of the 57 infants, 10 were lost to follow-up. Occurrence of seizures during the first 24 h, cranial ultrasonography (US) findings within the first 5 days of life, and Denver developmental screening test II (DDST II) at 6 months of age, were analyzed in relation to mortality and neurological status at 2 years of age. The primary aim of this study was to find widely available, inexpensive, and non-invasive parameters for early identification or prediction of the infants with hypoxic-ischemic encephalopathy (HIE) who will have a severe adverse outcome (classified as death or a major neurological deficit).įifty-seven full-term or near-term newborn infants with a diagnosis of HIE were consecutively admitted to the neonatal intensive care unit and studied.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |